MCO
70
-3
AMG
36
-7
LOW
49
-6
AON
32
-4
PX
12
-4
HCA
42
3
VFC
13
-3
MET
38
-15
FSLR
55
-3
DHR
44
-5
BIIB
38
2
VIX
44
-8
TXN
36
-12
DGX
48
-3
ROP
59
2
GWW
58
-2
PYPL
45
-5
MKC
45
-2
SCHW
56
-3
LNC
43
-3
MCO
70
-3
AMG
36
-7
LOW
49
-6
AON
32
-4
PX
12
-4
HCA
42
3
VFC
13
-3
MET
38
-15
FSLR
55
-3
DHR
44
-5
BIIB
38
2
VIX
44
-8
TXN
36
-12
DGX
48
-3
ROP
59
2
GWW
58
-2
PYPL
45
-5
MKC
45
-2
SCHW
56
-3
LNC
43
-3
Financhill
Back

Alaunos Therapeutics Quote, Financials, Valuation and Earnings

Elon's Secret "A.I. 2.0" Project

Click here now to discover how to claim a stake in Elon's "A.I. 2.0" project
Sell
21

TCRT
Alaunos Therapeutics

Last Price:
1.15
Seasonality Move:
15.89%

7 Day Trial

ALL ACCESS PASS

$ 7

DeFi Coin Triggers All "Buy" Signals And Could Break Out Soon

Discover our top DeFi pick for potentially massive gains now (before it's too late).

Alaunos Therapeutics Price Quote

$1.15
-0.01 (-2.54%)
(Updated: April 26, 2024 at 6:19 AM ET)

Alaunos Therapeutics Key Stats

Sell
21
Alaunos Therapeutics (TCRT) is a Sell
Day range:
$1.07 - $1.20
52-week range:
$0.66 - $10.47
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
0.00
P/B ratio:
2.95%
Volume:
9.3K
Avg. volume:
58.4K
1-year change:
-84.74%
Market cap:
$18.6M
Revenue:
$5K
EPS:
$-2.29

How Much Does Alaunos Therapeutics Make?

Data Unavailable

Is Alaunos Therapeutics Growing As A Company?

  • What Is Alaunos Therapeutics's Growth Rate Quarterly?
    Quarterly YoY revenue growth is -0.91%
  • What Is Alaunos Therapeutics's EPS Quarterly YoY Growth Rate?
    Quarterly, year-over-year diluted EPS growth rate is 0%

Alaunos Therapeutics Stock Price Performance

What Is Alaunos Therapeutics 52-Week High & Low?

Alaunos Therapeutics Price To Free Cash Flow

Data Unavailable

Is It Risky To Buy Alaunos Therapeutics?

Is Alaunos Therapeutics Cash Flow Positive?

  • What Is TCRT Cash Flow From Operations?
    Cash flow from operations (TTM) is -$30.1M
  • What Is Alaunos Therapeutics’s Cash Flow From Financing?
    Cash flow from financing (TTM) is -$18.1M
  • What Is Alaunos Therapeutics’s Cash Flow From Investing?
    Cash flow from investing (TTM) is $1.3M

Alaunos Therapeutics Return On Invested Capital

  • Is Management Doing A Good Job?
    TCRT return on invested capital is -127.62%
  • What Is Alaunos Therapeutics Return On Assets?
    ROA measures how assets are converting to revenues and is -103.84%
  • What Is TCRT Return On Equity?
    ROE is a measure of profitability and is -159.84%

Alaunos Therapeutics Earnings Date & Stock Price

Alaunos Therapeutics Competitors

Alaunos Therapeutics Dividend Yield

Data Unavailable

Alaunos Therapeutics Analyst Estimates

YoY Growth Past Surprise
EPS: 0% -279.87%
Revenue: -90.91% 0%

Analyst Recommendations

Buy Recommendations: 0
Hold Recommendations: 1
Sell Recommendations: 0
Price Target: 20.55
Upside from Last Price: 1671.55%

Major Shareholders

  • How many TCRT shares are owned by institutional investors?
    55.4M TCRT shares are owned by institutional investors
  • How many TCRT shares are owned by insiders?
    10.1M TCRT shares are owned by insiders